Worldwide Migraine Therapeutics Industry to 2025 - Key Drivers, Challenges and Trends - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Global Migraine Therapeutics Market 2021-2025" report has been added to ResearchAndMarkets.com's offering.

The publisher has been monitoring the migraine therapeutics market and it is poised to grow by $1.06 billion during 2021-2025 progressing at a CAGR of 5% during the forecast period.

The report on migraine therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the increase in the number of patients suffering from migraine and rise in the number of approvals for preventive drugs for migraine.

The migraine therapeutics market analysis includes product segment and geographical landscapes. This study identifies the rising advances in migraine therapeutics as one of the prime reasons driving the migraine therapeutics market growth during the next few years.

Companies Mentioned

• AbbVie Inc.
• Amgen Inc.
• Eli Lilly and Co.
• eNeura Inc.
• GlaxoSmithKline Plc
• Grunenthal GmbH
• H. Lundbeck AS
• Pfizer Inc.
• Teva Pharmaceutical Industries Ltd.
• Upsher-Smith Laboratories LLC

The report on migraine therapeutics market covers the following areas:

• Migraine therapeutics market sizing
• Migraine therapeutics market forecast
• Migraine therapeutics market industry analysis

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.

Key Topics Covered:

1. Executive Summary

• Market Overview

2. Market Landscape

• Market ecosystem
• Market characteristics
• Value chain analysis

3. Market Sizing

• Market definition
• Market segment analysis
• Market size 2020
• Market outlook: Forecast for 2020 - 2025

4. Five Forces Analysis

• Five forces summary
• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition

5. Market Segmentation by Product

• Market segments
• Comparison by Product
• Drugs - Market size and forecast 2020-2025
• Devices - Market size and forecast 2020-2025
• Market opportunity by Product

6. Market Segmentation by Treatment

• Preventive treatment
• Abortive treatment

7. Customer landscape

8. Geographic Landscape

• Geographic segmentation
• Geographic comparison
• North America - Market size and forecast 2020-2025
• Europe - Market size and forecast 2020-2025
• Asia - Market size and forecast 2020-2025
• ROW - Market size and forecast 2020-2025
• Key leading countries
• Market opportunity by geography
• Market drivers
• Market challenges
• Market trends

9. Vendor Landscape

• Vendor landscape
• Landscape disruption
• Competitive scenario

10. Vendor Analysis

• Vendors covered
• Market positioning of vendors
• AbbVie Inc.
• Amgen Inc.
• Eli Lilly and Co.
• eNeura Inc.
• GlaxoSmithKline Plc
• Grunenthal GmbH
• H. Lundbeck AS
• Pfizer Inc.
• Teva Pharmaceutical Industries Ltd.
• Upsher-Smith Laboratories LLC

11. Appendix

• Scope of the report
• Currency conversion rates for US$
• Research methodology
• List of abbreviations

For more information about this report visit https://www.researchandmarkets.com/r/d3gu15

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900